Abstract
Thymic epithelial tumors (TET) are rare tumors with an unknown etiology and risk factors. They have a known association with paraneoplastic syndromes, especially myasthenia gravis. Various histopathological classifications have been described, the most used of which is the World Health Organization classification. A definitive diagnosis of TET is made via a biopsy. A differential diagnosis with other tumors of the anterior mediastinum is necessary. A computerized tomography (CT) scan is the test of choice for the staging of the disease. The most used staging system is the Masaoka system, which adequately correlates with survival. Treatment of TET is based on a complete tumor resection. Radiotherapy and chemotherapy can be used as induction, adjuvant, or palliative treatment. However, optimal therapy is still a subject of debate.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
